The use of apixaban for stroke prevention in patients with atrial fibrillation (AF) and liver cirrhosis appears to be safer than other common anticoagulants, a new observational study shows. When ...

Apixaban for AF in End-Stage Renal Disease: Fewer Strokes, Major Bleeds vs Warfarin. Steve Stiles. July 31, 2018. Treatment with apixaban (Eliquis, Bristol-Myers Squibb/Pfizer), regardless of ...

Barcelona, Spain - 28 Aug 2017: Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according ...

Compared with the apixaban group, patients with AF who were taking rivaroxaban had greater risk for secondary outcomes including: nonfatal extracranial bleeding (39.7 vs. 18.5 per 1,000 person ...

The FDA has finally approved apixaban (Eliquis, Bristol Myers Squibb and Pfizer) to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.The action ...

Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a ...

The use of apixaban (Eliquis; Bristol-Myers Squibb) over rivaroxaban (Xarelto; Bayer/Janssen) in patients with atrial fibrillation (AF) and valvular heart disease is associated with better clinical ...

Of 18,201 patients with AF and at least one risk factor for stroke who were randomized in ARISTOTLE, 18,197 patients had data on valvular heart disease status, and of these, 4808 patients (26.4% ...

Key takeaways: Apixaban tied to less stroke and bleeding in patients with/without dementia vs. dabigatran, rivaroxaban or warfarin. This association was strongest for the outcome of major bleeding.

The benefits of apixaban on stroke/systemic embolism and all-cause death vs. warfarin are similar in patients with and without peripheral artery disease (PAD), but a greater reduction in bleeding ...

Apixaban is currently the most prescribed oral anticoagulant in the general population and in people with HIV. ... (Afib or AF), certain oral anticoagulants (OACs) ...

They reviewed the case of Dr. G, a 63-year-old man who noticed an irregular heart rate while biking to work and an electrocardiogram confirmed AF. Dr. G has a history of hypertension and ...